This article addresses the evolving role of invasive mediastinal restaging in managing resectable stage II and III NSCLC in the era of neoadjuvant chemoimmunotherapy.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Cancer
January 2, 2025
This study evaluates the outcomes of bilateral lung transplantation (LTx) using grafts from donors aged 70 years or older, compared with those from younger donors. Conducted at a single center in Leuven, Belgium, the retrospective cohort study included 69 older donors, matched 1:1 with younger donors based on key variables.
November 21, 2024
Current guidelines advocate for surgically placed intercoastal catheters (ICC) for pain optimization following minimally invasive anatomic lung resection. This double-blind, randomized study aimed to determine the efficacy of loco-regional continuous ropivacaine application through ICC as a method of providing analgesia postoperatively.
October 24, 2024
This article evaluates the effectiveness of neoadjuvant immunotherapy combined with chemotherapy (IC+Chemo) in treating non-small cell lung cancer (NSCLC). This large-scale study involved 1,092 patients from 11 medical centers and compared outcomes between those who received IC+Chemo and those who received chemotherapy alone.
May 29, 2024
This study evaluated the surgical and oncological results of RATS thymectomy to demonstrate the approach as technically safe with acceptable outcomes. Of 669 patients, complete thymectomy was performed in 98 percent of cases and in 8.5 percent of those cases, resection of surrounding structures was undertaken.
May 23, 2024
Sublobar resection for early-stage non-small cell lung cancer has recently been compared with lobectomy in three randomized trials. This expert review summarizes and compares these three landmark trials and describes how these new data inform best practice.
May 2, 2024
Of 57,531 patients who underwent lung cancer resection identified from The Society of Thoracic Surgeons General Thoracic Surgery Database, 758 (1.3 percent) were diagnosed with pulmonary embolism, which was most likely in patients with locally advanced disease who underwent bilobectomy (6 percent versus 4 percent, P < .001) or pneumonectomy (8 per
April 18, 2024
This study reviews 44 patients with stage IB (larger than 4 cm) to IIIA non-small cell lung cancer who were treated on sequential platform arms of the NEOSTAR trial. Twenty-two patients were treated with nivolumab and chemotherapy and 22 patients were treated with ipilimumab, nivolumab, and chemotherapy.
April 10, 2024
The authors of this paper explored early postoperative outcomes in all patients (n= 833) undergoing uniportal segmentectomy and lobectomy in their unit between 2017 and 2022. During this study period, the utilization of uniportal access operations increased.
March 27, 2024
This study aimed to evaluate the percentage of solitary fibrous pleural tumors presenting unfavorable clinical behavior to predict negative long-term outcomes.